Company states variant-specific booster still in the works. The makers of the Moderna COVID-19 vaccine say a booster dose bolsters the body’s immune response to the Omicron variant—encouraging…
Read MoreModerna
NIH Studies Allergic Reactions to Vaccines
The National Institutes of Health has begun a clinical trial to determine allergic reactions to the Pfizer-BioNTech and Moderna COVID-19 vaccines. The trial seeks to discover whether systemic…
Read More
Vaccine Trials for Children Begin
“KidCOVE” study involves Moderna and NIH. Moderna announced Tuesday it has begun clinical trials of its two-dose vaccine in children from six months to 11 years in both…
Read More